Synapse Open Synapse
Science

Are T cell ‘engagers’ the next big thing in autoimmune disease treatment?

Science Magazine · · 6 min read

Engineered antibodies may produce remissions and offer safety benefits over cell therapies that have killed patients

Latest from Science Magazine